It is our great pleasure to announce that Iris Benhayoun has joined our team as an independent consultant. Iris will assist in WHVs HIV vaccine development including the upcoming WHV138 clinical trial study.
Iris holds a Master of Science in Epidemiology from the University of Massachusetts Amherst and comes with an extensive background in trial studies. Most recently, Iris worked as a clinical research coordinator for both the Specialty Retina Center and the Specialty Gastro Center where she was responsible for patient recruitment and retention, as well as the preparation of clinical offices to comply with sponsor requirements for study site selections.
Previously, Iris worked at the Global HIV Vaccine Enterprise assisting in the Timely Topics in HIV Vaccine initiative. She helped create print and online guidance materials for researchers working on the development of a safe and effective HIV Vaccine.
Iris’ experience at the HIV Enterprise and in clinical trial studies makes her a perfect match for WHVs 138 trial and we are extremely excited to have her on board.
